all report title image

EXOSOMES DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Exosomes Diagnostic and Therapeutic Market, By Type (Exosome Diagnostics and Exosome Therapeutics), By Product & Service (Instruments & Services and Kits & Reagents), By Source (Stem Cells, Blood & Blood Plasma, Urine, and Other Sources), By Application (Cancer, Dermatological Diseases, Musculoskeletal Disorders, Cardiovascular Diseases, and Others), By End User (Hospitals & Diagnostic Centers, Clinics and Physician Settings, Academic and Research Institutions, Contract Research Organizations, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Aug 2024
  • Code : CMI7310
  • Pages :140
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Exosomes Diagnostic and Therapeutic Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Growing applications of exosomes in drug discovery and clinical diagnostics

Research on extracellular vesicles called exosomes has opened up new avenues for investigation in various areas of healthcare. Initially considered as cellular waste handlers, scientists are now exploring the immense potential of exosomes in non-invasive disease diagnosis, therapeutic monitoring and drug development. Several proof-of-concept studies have validated exosomes applications as biomarkers for conditions like cancer, neurodegenerative diseases, cardiovascular disorders, and infectious diseases. Owing to their nanoscale size and bioactive molecular cargo stable enough to travel in body fluids, exosomes hold promise as non-invasive, real time disease trackers with high sensitivity and specificity compared to conventional markers.

In the area of drug discovery, exosomes enable encapsulation and delivery of therapeutic payloads to target sites with lower toxicity. Their membrane properties and molecular recognition capacities make them well suited for development as innovative drug delivery systems. Several biotechnology companies are conducting R&D on modifying exosomes as nanocarriers and loading them with drugs, antibodies, RNA molecules or other agents for enhanced efficacy. Their endogenous origin also makes exosome mediated therapeutics potentially less immunogenic and more biocompatible. Researchers are also investigating transferring siRNAs, miRNAs and other regulatory molecules to recipient cells via exosomes for developing novel gene therapies.

As advancements continue to unfold new facets of intercellular communication using exosomes, opportunities in precision medicine are expanding too. Integrating molecular profiling of exosomal cargo with clinical data presents potential for personalized diagnostics, disease monitoring and treatment optimization approaches.

Key Players Insights
    • Thermo Fisher Scientific
    • NanoSomix
    • NX Pharmagen
    • Malvern Instruments
    • Capricor Therapeutic
    • Exosome Diagnostics
    • Exiqon A/S
    • System Biosciences
    • Exosome Sciences
    • Aegle Therapeutic
    • AMS Biotechnology
    • Miltenyi Biotec
    • Codiak BioSciences Inc.
    • Lonza Group (HansaBioMed Life Sciences Ltd.)
    • AcouSort AB
    • Aethlon Medical, Inc.
    • AGC Biologics
    • Anjarium Biosciences AG
    • Aruna Bio
    • Brexogen
    • Capricor Therapeutics
    • Cells for Cells
    • Ciloa
    • ConvEyXO
  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
    Logo

    Credibility and Certifications

    ESOMAR
    DUNS Registered
    Clutch
    DMCA Protected

    9001:2015

    Credibility and Certifications

    27001:2022

    Credibility and Certifications

    EXISTING CLIENTELE

    Joining thousands of companies around the world committed to making the Excellent Business Solutions.

    View All Our Clients
    trusted clients logo
    © 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.